You should consider the fact that EpiPen is 'off patent' and that it is priced at some high number by a generic company and that there apparently are no others.
The 'market is speaking'.
If it were in way lucrative, someone would be doing it.
I suggest that it's just a very expensive thing to develop and make, and there isn't a huge demand - otherwise, someone probably would.
Now, $600 seems just crazy to me, and like you, my instinct might be 'there's room for someone' - but in reality, it's never that easy.
My father worked in Pharma, and once sold a small empty building on behalf of a company for huge $$$ to a Chinese firm - only because it was 'approved' by the Canadian government for making drugs of a certain quality, and that this approval would have been very expensive to obtain. This is just at the top of the list of how many regulatory issues there are in making drugs - and why they are so expensive.
I mean it does seem a little crazy that there are $600 EpiPen's but no others - when anyone can make them, but that's where we are.
The 'market is speaking'.
If it were in way lucrative, someone would be doing it.
I suggest that it's just a very expensive thing to develop and make, and there isn't a huge demand - otherwise, someone probably would.
Now, $600 seems just crazy to me, and like you, my instinct might be 'there's room for someone' - but in reality, it's never that easy.
My father worked in Pharma, and once sold a small empty building on behalf of a company for huge $$$ to a Chinese firm - only because it was 'approved' by the Canadian government for making drugs of a certain quality, and that this approval would have been very expensive to obtain. This is just at the top of the list of how many regulatory issues there are in making drugs - and why they are so expensive.
I mean it does seem a little crazy that there are $600 EpiPen's but no others - when anyone can make them, but that's where we are.